| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone-Lysine N-Methyltransferase | 10 | 2021 | 461 | 3.030 |
Why?
|
| Leiomyoma | 18 | 2023 | 145 | 2.950 |
Why?
|
| Peroxisomes | 5 | 2018 | 49 | 2.660 |
Why?
|
| Tumor Suppressor Proteins | 26 | 2015 | 1823 | 2.490 |
Why?
|
| Uterine Neoplasms | 17 | 2016 | 545 | 2.210 |
Why?
|
| Epigenesis, Genetic | 20 | 2022 | 1399 | 2.190 |
Why?
|
| Endocrine Disruptors | 10 | 2023 | 53 | 2.010 |
Why?
|
| Autophagy | 13 | 2020 | 927 | 1.940 |
Why?
|
| Carcinoma, Renal Cell | 17 | 2023 | 2326 | 1.940 |
Why?
|
| Reactive Oxygen Species | 8 | 2018 | 987 | 1.700 |
Why?
|
| Kidney Neoplasms | 19 | 2023 | 3022 | 1.670 |
Why?
|
| TOR Serine-Threonine Kinases | 19 | 2015 | 1546 | 1.540 |
Why?
|
| Signal Transduction | 32 | 2019 | 11965 | 1.320 |
Why?
|
| Lysine | 5 | 2020 | 422 | 1.310 |
Why?
|
| Estrogens | 9 | 2014 | 751 | 1.270 |
Why?
|
| Actins | 2 | 2020 | 608 | 1.220 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 6 | 2016 | 430 | 1.190 |
Why?
|
| Carcinoma, Medullary | 5 | 2023 | 248 | 1.180 |
Why?
|
| Environmental Exposure | 12 | 2021 | 288 | 1.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2019 | 268 | 1.060 |
Why?
|
| DNA-Binding Proteins | 7 | 2016 | 4821 | 1.020 |
Why?
|
| Multiprotein Complexes | 7 | 2015 | 395 | 1.010 |
Why?
|
| SMARCB1 Protein | 4 | 2023 | 109 | 1.010 |
Why?
|
| Histones | 11 | 2021 | 1466 | 0.950 |
Why?
|
| Rats | 35 | 2023 | 6086 | 0.940 |
Why?
|
| Microtubules | 6 | 2021 | 270 | 0.940 |
Why?
|
| Disease Susceptibility | 5 | 2019 | 538 | 0.930 |
Why?
|
| Diethylstilbestrol | 4 | 2010 | 109 | 0.930 |
Why?
|
| Protein Kinases | 6 | 2010 | 874 | 0.930 |
Why?
|
| Cytoskeleton | 4 | 2021 | 267 | 0.900 |
Why?
|
| Cytoplasm | 4 | 2011 | 652 | 0.890 |
Why?
|
| Tubulin | 3 | 2021 | 169 | 0.890 |
Why?
|
| Methylation | 9 | 2021 | 597 | 0.820 |
Why?
|
| Animals | 80 | 2023 | 59536 | 0.810 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 4 | 2011 | 287 | 0.810 |
Why?
|
| Proteostasis | 2 | 2019 | 52 | 0.760 |
Why?
|
| Estrogens, Non-Steroidal | 5 | 2017 | 44 | 0.740 |
Why?
|
| Cell Cycle Proteins | 5 | 2017 | 2045 | 0.730 |
Why?
|
| Polycystic Kidney Diseases | 3 | 2006 | 34 | 0.710 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2016 | 1498 | 0.700 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 321 | 0.680 |
Why?
|
| Repressor Proteins | 8 | 2005 | 1664 | 0.650 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2019 | 132 | 0.650 |
Why?
|
| Histone Code | 3 | 2019 | 79 | 0.610 |
Why?
|
| Receptors, Estrogen | 3 | 2013 | 2086 | 0.610 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 534 | 0.610 |
Why?
|
| Environmental Pollutants | 3 | 2020 | 83 | 0.600 |
Why?
|
| Gene-Environment Interaction | 3 | 2020 | 166 | 0.580 |
Why?
|
| Microbiota | 1 | 2023 | 547 | 0.580 |
Why?
|
| Membrane Proteins | 6 | 2020 | 2819 | 0.570 |
Why?
|
| 14-3-3 Proteins | 3 | 2016 | 143 | 0.570 |
Why?
|
| Endometrial Neoplasms | 5 | 2010 | 1341 | 0.570 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2014 | 155 | 0.570 |
Why?
|
| Proteomics | 2 | 2023 | 1380 | 0.560 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 591 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2018 | 2359 | 0.550 |
Why?
|
| Organelles | 1 | 2016 | 40 | 0.550 |
Why?
|
| Transcription Factors | 6 | 2022 | 5270 | 0.550 |
Why?
|
| MCF-7 Cells | 8 | 2017 | 550 | 0.540 |
Why?
|
| Homeostasis | 2 | 2018 | 950 | 0.530 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 287 | 0.520 |
Why?
|
| Epigenomics | 6 | 2020 | 266 | 0.520 |
Why?
|
| Reproduction | 3 | 2008 | 253 | 0.520 |
Why?
|
| Phosphorylation | 15 | 2016 | 4804 | 0.510 |
Why?
|
| Anemia, Sickle Cell | 2 | 2018 | 339 | 0.510 |
Why?
|
| Endometrial Hyperplasia | 3 | 2010 | 112 | 0.510 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 6 | 2015 | 265 | 0.510 |
Why?
|
| Methyltransferases | 1 | 2016 | 148 | 0.510 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2013 | 413 | 0.500 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 197 | 0.490 |
Why?
|
| Autism Spectrum Disorder | 5 | 2022 | 363 | 0.490 |
Why?
|
| Humans | 92 | 2023 | 261506 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2010 | 2054 | 0.480 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2016 | 1678 | 0.470 |
Why?
|
| Adenylate Kinase | 2 | 2010 | 36 | 0.460 |
Why?
|
| Aurora Kinase A | 1 | 2014 | 202 | 0.460 |
Why?
|
| Cell Line | 10 | 2020 | 5114 | 0.460 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2009 | 986 | 0.450 |
Why?
|
| DNA Methylation | 11 | 2022 | 2669 | 0.450 |
Why?
|
| Hormones | 3 | 2016 | 266 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2020 | 8873 | 0.430 |
Why?
|
| TRPP Cation Channels | 2 | 2010 | 11 | 0.430 |
Why?
|
| Maternal Exposure | 4 | 2019 | 160 | 0.430 |
Why?
|
| Myometrium | 5 | 2016 | 79 | 0.420 |
Why?
|
| Genistein | 1 | 2012 | 73 | 0.420 |
Why?
|
| beta Catenin | 2 | 2014 | 688 | 0.410 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2021 | 803 | 0.410 |
Why?
|
| Cell Membrane | 5 | 2016 | 850 | 0.410 |
Why?
|
| Genitalia, Male | 1 | 2011 | 36 | 0.400 |
Why?
|
| Blotting, Western | 9 | 2016 | 3536 | 0.400 |
Why?
|
| Cells | 1 | 2011 | 31 | 0.390 |
Why?
|
| Immunohistochemistry | 7 | 2016 | 7548 | 0.390 |
Why?
|
| Benzhydryl Compounds | 4 | 2017 | 85 | 0.390 |
Why?
|
| Phenols | 4 | 2017 | 107 | 0.380 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2006 | 1064 | 0.380 |
Why?
|
| Placenta | 5 | 2022 | 516 | 0.380 |
Why?
|
| Genitalia, Female | 1 | 2011 | 68 | 0.380 |
Why?
|
| Mitochondria | 1 | 2018 | 1282 | 0.380 |
Why?
|
| Autistic Disorder | 3 | 2022 | 319 | 0.380 |
Why?
|
| Multienzyme Complexes | 2 | 2008 | 213 | 0.370 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 703 | 0.370 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 88 | 0.360 |
Why?
|
| Disasters | 2 | 2021 | 107 | 0.350 |
Why?
|
| Cell Line, Tumor | 14 | 2020 | 14551 | 0.330 |
Why?
|
| HEK293 Cells | 5 | 2016 | 1489 | 0.330 |
Why?
|
| Carcinogens | 3 | 2008 | 384 | 0.320 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 195 | 0.320 |
Why?
|
| Protein Binding | 6 | 2021 | 3438 | 0.320 |
Why?
|
| Uterus | 3 | 2010 | 678 | 0.320 |
Why?
|
| Prostatic Neoplasms | 3 | 2016 | 5767 | 0.310 |
Why?
|
| Pregnancy | 17 | 2022 | 7573 | 0.300 |
Why?
|
| Activin Receptors, Type I | 1 | 2007 | 50 | 0.300 |
Why?
|
| Disease Models, Animal | 10 | 2016 | 7222 | 0.300 |
Why?
|
| Mitosis | 3 | 2016 | 615 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 1265 | 0.300 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 3639 | 0.290 |
Why?
|
| Female | 54 | 2023 | 141928 | 0.290 |
Why?
|
| Trichloroethylene | 1 | 2006 | 5 | 0.290 |
Why?
|
| Quinoxalines | 1 | 2007 | 95 | 0.280 |
Why?
|
| Solvents | 1 | 2006 | 66 | 0.280 |
Why?
|
| Mice | 24 | 2023 | 34495 | 0.280 |
Why?
|
| Mice, Knockout | 10 | 2019 | 5710 | 0.280 |
Why?
|
| Infertility, Female | 1 | 2008 | 217 | 0.270 |
Why?
|
| Trans-Activators | 2 | 2003 | 1555 | 0.270 |
Why?
|
| Hydrogen Peroxide | 2 | 2018 | 217 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 2 | 2016 | 4367 | 0.270 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2007 | 229 | 0.270 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2004 | 145 | 0.260 |
Why?
|
| Rats, Mutant Strains | 6 | 2010 | 23 | 0.260 |
Why?
|
| Biomarkers | 7 | 2023 | 5047 | 0.260 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3230 | 0.260 |
Why?
|
| Cysteine | 1 | 2006 | 214 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2008 | 5539 | 0.260 |
Why?
|
| Penetrance | 1 | 2005 | 126 | 0.260 |
Why?
|
| Kidney | 4 | 2023 | 2146 | 0.250 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2014 | 376 | 0.250 |
Why?
|
| Sirolimus | 4 | 2010 | 814 | 0.250 |
Why?
|
| Cellular Reprogramming | 3 | 2016 | 189 | 0.250 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 216 | 0.240 |
Why?
|
| Proteins | 5 | 2010 | 1963 | 0.240 |
Why?
|
| Environmental Health | 1 | 2023 | 21 | 0.230 |
Why?
|
| Isochromosomes | 1 | 2023 | 55 | 0.230 |
Why?
|
| Sickle Cell Trait | 1 | 2023 | 31 | 0.230 |
Why?
|
| Tuberous Sclerosis | 4 | 2010 | 136 | 0.230 |
Why?
|
| Anxiety | 2 | 2021 | 1179 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 182 | 0.220 |
Why?
|
| Genes, cdc | 1 | 2003 | 81 | 0.220 |
Why?
|
| Biological Assay | 2 | 2016 | 177 | 0.220 |
Why?
|
| Vascular Neoplasms | 1 | 2003 | 114 | 0.220 |
Why?
|
| Mothers | 2 | 2016 | 410 | 0.220 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 79 | 0.220 |
Why?
|
| Thiophenes | 1 | 2003 | 148 | 0.210 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 148 | 0.210 |
Why?
|
| Serine | 2 | 2015 | 388 | 0.200 |
Why?
|
| Imidazoles | 1 | 2007 | 999 | 0.200 |
Why?
|
| Deer | 1 | 2021 | 11 | 0.200 |
Why?
|
| Floods | 1 | 2021 | 17 | 0.190 |
Why?
|
| Genomic Instability | 3 | 2023 | 519 | 0.190 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 57 | 0.190 |
Why?
|
| Reading | 1 | 2021 | 81 | 0.190 |
Why?
|
| Disaster Planning | 1 | 2021 | 68 | 0.190 |
Why?
|
| Cells, Cultured | 6 | 2017 | 5637 | 0.190 |
Why?
|
| Estradiol | 4 | 2010 | 748 | 0.190 |
Why?
|
| Organotin Compounds | 1 | 2020 | 8 | 0.180 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2012 | 160 | 0.180 |
Why?
|
| Catalytic Domain | 1 | 2021 | 303 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2022 | 224 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 8 | 2020 | 5395 | 0.180 |
Why?
|
| DNA Replication | 2 | 2023 | 744 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 3 | 2015 | 769 | 0.180 |
Why?
|
| Chromatin | 3 | 2021 | 942 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2019 | 16 | 0.180 |
Why?
|
| Sequence Deletion | 1 | 2003 | 875 | 0.180 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 276 | 0.180 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2012 | 245 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 492 | 0.180 |
Why?
|
| Hypoxia | 2 | 2023 | 443 | 0.170 |
Why?
|
| Carcinogenesis | 4 | 2023 | 1026 | 0.170 |
Why?
|
| Depression, Postpartum | 1 | 2019 | 45 | 0.170 |
Why?
|
| Health Promotion | 1 | 2023 | 502 | 0.170 |
Why?
|
| Tamoxifen | 1 | 2003 | 876 | 0.170 |
Why?
|
| Prostate | 2 | 2015 | 1088 | 0.170 |
Why?
|
| Carcinoma | 1 | 2010 | 2578 | 0.160 |
Why?
|
| Loss of Heterozygosity | 4 | 2009 | 602 | 0.160 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 26 | 0.160 |
Why?
|
| RNA Interference | 2 | 2015 | 1408 | 0.160 |
Why?
|
| Hyperoxia | 1 | 2020 | 133 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 216 | 0.160 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 110 | 0.160 |
Why?
|
| Osmotic Pressure | 1 | 2018 | 47 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2018 | 77 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 650 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2003 | 840 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 194 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 2063 | 0.160 |
Why?
|
| Piperidines | 1 | 2003 | 1035 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2019 | 239 | 0.160 |
Why?
|
| HeLa Cells | 5 | 2017 | 1643 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2017 | 43 | 0.150 |
Why?
|
| Mad2 Proteins | 1 | 2017 | 33 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 2403 | 0.150 |
Why?
|
| Lymphangioleiomyomatosis | 2 | 2010 | 25 | 0.150 |
Why?
|
| Estrogen Receptor beta | 2 | 2017 | 155 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 204 | 0.150 |
Why?
|
| Models, Biological | 5 | 2016 | 3254 | 0.150 |
Why?
|
| Risk Factors | 9 | 2017 | 17523 | 0.150 |
Why?
|
| PDZ Domains | 1 | 2016 | 20 | 0.150 |
Why?
|
| Cell Compartmentation | 1 | 2016 | 76 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2018 | 1442 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2019 | 306 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 2216 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2010 | 886 | 0.140 |
Why?
|
| Rats, Inbred Strains | 2 | 2007 | 410 | 0.140 |
Why?
|
| Chromosome Aberrations | 2 | 2023 | 1960 | 0.140 |
Why?
|
| Fetal Proteins | 1 | 2016 | 28 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2018 | 311 | 0.140 |
Why?
|
| Male | 23 | 2021 | 123000 | 0.140 |
Why?
|
| Cytokinesis | 1 | 2016 | 57 | 0.140 |
Why?
|
| Peroxisome-Targeting Signal 1 Receptor | 1 | 2015 | 3 | 0.140 |
Why?
|
| Stress, Psychological | 2 | 2021 | 1000 | 0.140 |
Why?
|
| Organ Specificity | 2 | 2011 | 699 | 0.140 |
Why?
|
| Sequestosome-1 Protein | 1 | 2015 | 39 | 0.140 |
Why?
|
| Phagosomes | 1 | 2015 | 72 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 155 | 0.130 |
Why?
|
| Mammaglobin B | 1 | 2015 | 1 | 0.130 |
Why?
|
| Growth and Development | 1 | 2015 | 28 | 0.130 |
Why?
|
| Maternal Behavior | 1 | 2015 | 62 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2020 | 2074 | 0.130 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 209 | 0.130 |
Why?
|
| Health | 1 | 2015 | 54 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2005 | 110 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 518 | 0.130 |
Why?
|
| Growth Substances | 2 | 2006 | 300 | 0.130 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 600 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 467 | 0.120 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1471 | 0.120 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2014 | 23 | 0.120 |
Why?
|
| Carotenoids | 1 | 2015 | 96 | 0.120 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 43 | 0.120 |
Why?
|
| Cilia | 1 | 2014 | 92 | 0.120 |
Why?
|
| Mammals | 1 | 2016 | 361 | 0.120 |
Why?
|
| Medical Records | 1 | 2015 | 415 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 308 | 0.120 |
Why?
|
| Biomarkers, Tumor | 4 | 2020 | 10331 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2010 | 1129 | 0.120 |
Why?
|
| Brain | 4 | 2022 | 4113 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 3203 | 0.110 |
Why?
|
| Disease | 1 | 2015 | 165 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 701 | 0.110 |
Why?
|
| Rats, Long-Evans | 2 | 2003 | 101 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 6942 | 0.110 |
Why?
|
| Antibodies | 1 | 2016 | 838 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 129 | 0.110 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2012 | 8 | 0.110 |
Why?
|
| Misoprostol | 1 | 2012 | 19 | 0.110 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 362 | 0.110 |
Why?
|
| Autoantibodies | 1 | 2016 | 576 | 0.110 |
Why?
|
| Memory | 1 | 2015 | 429 | 0.100 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 268 | 0.100 |
Why?
|
| Cell Division | 4 | 2003 | 2489 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 421 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 336 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2014 | 382 | 0.100 |
Why?
|
| Proteome | 1 | 2015 | 561 | 0.100 |
Why?
|
| Epithelium | 1 | 2014 | 720 | 0.100 |
Why?
|
| Genome, Human | 3 | 2016 | 1869 | 0.100 |
Why?
|
| California | 3 | 2018 | 208 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 1439 | 0.100 |
Why?
|
| Mutation | 5 | 2021 | 15179 | 0.100 |
Why?
|
| Patient Selection | 1 | 2018 | 2055 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 2287 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7789 | 0.090 |
Why?
|
| Stem Cells | 2 | 2015 | 1213 | 0.090 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2011 | 178 | 0.090 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2010 | 26 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2012 | 875 | 0.090 |
Why?
|
| Mercury | 1 | 2010 | 32 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 336 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2011 | 249 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 1130 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 663 | 0.090 |
Why?
|
| DNA Repair | 2 | 2023 | 1872 | 0.090 |
Why?
|
| Depression | 1 | 2019 | 1715 | 0.090 |
Why?
|
| DNA Damage | 2 | 2023 | 1954 | 0.090 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2009 | 84 | 0.090 |
Why?
|
| Apoptosis | 4 | 2020 | 7591 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 3154 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2022 | 8223 | 0.080 |
Why?
|
| Calcium | 1 | 2015 | 1537 | 0.080 |
Why?
|
| Gene Silencing | 3 | 2015 | 837 | 0.080 |
Why?
|
| Cell Proliferation | 5 | 2020 | 7226 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.080 |
Why?
|
| Genotype | 2 | 2010 | 4109 | 0.080 |
Why?
|
| Thymidine Kinase | 1 | 2009 | 193 | 0.080 |
Why?
|
| Cell Death | 1 | 2011 | 671 | 0.080 |
Why?
|
| Obesity | 4 | 2017 | 2884 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 1070 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 201 | 0.080 |
Why?
|
| COS Cells | 2 | 2021 | 377 | 0.080 |
Why?
|
| Chromones | 1 | 2008 | 120 | 0.080 |
Why?
|
| Genital Diseases, Female | 1 | 2008 | 60 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 3719 | 0.080 |
Why?
|
| Cytosol | 1 | 2008 | 238 | 0.080 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2008 | 56 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2009 | 6150 | 0.080 |
Why?
|
| Cadherins | 2 | 2019 | 660 | 0.080 |
Why?
|
| Calbindins | 1 | 2007 | 21 | 0.080 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2007 | 68 | 0.080 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 575 | 0.080 |
Why?
|
| Androstadienes | 1 | 2008 | 165 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2014 | 1818 | 0.070 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2007 | 50 | 0.070 |
Why?
|
| Adult | 9 | 2021 | 77950 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2020 | 1338 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 56 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2012 | 554 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 14289 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 1062 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 501 | 0.070 |
Why?
|
| Glutamates | 1 | 2007 | 130 | 0.070 |
Why?
|
| Kidney Tubules | 1 | 2007 | 137 | 0.070 |
Why?
|
| Benzoates | 1 | 2007 | 136 | 0.070 |
Why?
|
| Morpholines | 1 | 2008 | 289 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 2006 | 35 | 0.070 |
Why?
|
| Angiotensin II | 1 | 2007 | 198 | 0.070 |
Why?
|
| Carcinogenicity Tests | 1 | 2006 | 70 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3552 | 0.070 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 2265 | 0.070 |
Why?
|
| Endometrium | 1 | 2010 | 470 | 0.070 |
Why?
|
| DNA | 2 | 2022 | 2693 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2003 | 212 | 0.070 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 197 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3981 | 0.070 |
Why?
|
| Time Factors | 4 | 2014 | 12926 | 0.070 |
Why?
|
| Lymphokines | 2 | 2003 | 272 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 4233 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2018 | 1682 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2015 | 2450 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 630 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 15694 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 643 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2020 | 810 | 0.060 |
Why?
|
| Microscopy | 2 | 2017 | 182 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2007 | 428 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 6682 | 0.060 |
Why?
|
| Diabetes, Gestational | 2 | 2016 | 104 | 0.060 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2003 | 36 | 0.060 |
Why?
|
| Acetylation | 2 | 2015 | 508 | 0.060 |
Why?
|
| Streptozocin | 1 | 2003 | 75 | 0.060 |
Why?
|
| Centromere | 1 | 2023 | 97 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1945 | 0.060 |
Why?
|
| Prevalence | 2 | 2016 | 3260 | 0.060 |
Why?
|
| Cytogenetics | 1 | 2023 | 149 | 0.060 |
Why?
|
| Neoplasms | 3 | 2017 | 15193 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2009 | 1459 | 0.060 |
Why?
|
| Risk | 2 | 2019 | 1972 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2004 | 167 | 0.060 |
Why?
|
| Prostaglandin D2 | 1 | 2003 | 26 | 0.060 |
Why?
|
| Chromans | 1 | 2003 | 31 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2003 | 52 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 5159 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2003 | 46 | 0.060 |
Why?
|
| Receptors, Oxytocin | 1 | 2003 | 23 | 0.060 |
Why?
|
| Base Sequence | 2 | 2015 | 4917 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2008 | 1620 | 0.060 |
Why?
|
| HMGA2 Protein | 1 | 2002 | 19 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 2508 | 0.050 |
Why?
|
| Cell Survival | 1 | 2009 | 3045 | 0.050 |
Why?
|
| Ultrasonic Therapy | 1 | 2002 | 55 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 741 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2022 | 69 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 368 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 682 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 215 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2020 | 4307 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4143 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 1077 | 0.050 |
Why?
|
| Hydroquinones | 2 | 2017 | 28 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2018 | 16273 | 0.050 |
Why?
|
| ras Proteins | 1 | 2006 | 770 | 0.050 |
Why?
|
| Adenoma | 1 | 2007 | 716 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2003 | 543 | 0.050 |
Why?
|
| CpG Islands | 2 | 2015 | 633 | 0.050 |
Why?
|
| Germ-Line Mutation | 2 | 2007 | 1046 | 0.050 |
Why?
|
| Progesterone | 1 | 2004 | 513 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 1375 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2002 | 177 | 0.050 |
Why?
|
| Sociological Factors | 1 | 2021 | 9 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 236 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2009 | 1616 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 1392 | 0.050 |
Why?
|
| Industry | 1 | 2021 | 53 | 0.050 |
Why?
|
| Karyotyping | 1 | 2003 | 1022 | 0.050 |
Why?
|
| Liver | 2 | 2017 | 2961 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2007 | 992 | 0.050 |
Why?
|
| Leiomyosarcoma | 1 | 2002 | 223 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 1099 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 13310 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1879 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 1399 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 842 | 0.050 |
Why?
|
| Heterozygote | 1 | 2003 | 1020 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2003 | 665 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2006 | 691 | 0.050 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2003 | 604 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 4053 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2022 | 717 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 995 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 82 | 0.050 |
Why?
|
| Glutathione | 1 | 2002 | 368 | 0.050 |
Why?
|
| Phenotype | 2 | 2021 | 6295 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 2283 | 0.050 |
Why?
|
| Carboplatin | 1 | 2023 | 823 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 67 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 50 | 0.040 |
Why?
|
| Bottle Feeding | 1 | 2019 | 36 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2002 | 798 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2003 | 1533 | 0.040 |
Why?
|
| North Carolina | 1 | 2019 | 125 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2003 | 622 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 124 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 2291 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 1058 | 0.040 |
Why?
|
| Oogenesis | 1 | 2019 | 71 | 0.040 |
Why?
|
| Incidence | 1 | 2009 | 5673 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 170 | 0.040 |
Why?
|
| Thiazoles | 1 | 2003 | 726 | 0.040 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2018 | 4 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 115 | 0.040 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2018 | 34 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 6089 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 237 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2019 | 259 | 0.040 |
Why?
|
| Prognosis | 3 | 2020 | 21713 | 0.040 |
Why?
|
| Cell Movement | 2 | 2002 | 2466 | 0.040 |
Why?
|
| Proteasome Inhibitors | 1 | 2019 | 231 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2018 | 142 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2019 | 397 | 0.040 |
Why?
|
| Myocardium | 1 | 2003 | 1313 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2016 | 6869 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 476 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 9244 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 310 | 0.040 |
Why?
|
| Oocytes | 1 | 2019 | 414 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2018 | 294 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2017 | 233 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 515 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2017 | 369 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 5687 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2019 | 901 | 0.030 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2016 | 295 | 0.030 |
Why?
|
| Embryology | 1 | 2015 | 3 | 0.030 |
Why?
|
| Trypsin | 1 | 2015 | 140 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2016 | 249 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 508 | 0.030 |
Why?
|
| Boston | 1 | 2015 | 108 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6100 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 298 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2022 | 12873 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3821 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4638 | 0.030 |
Why?
|
| Steroids | 1 | 2016 | 356 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 1113 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2015 | 131 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2015 | 72 | 0.030 |
Why?
|
| Ras Homolog Enriched in Brain Protein | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 905 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 545 | 0.030 |
Why?
|
| Genome | 1 | 2018 | 672 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 181 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 597 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 413 | 0.030 |
Why?
|
| Prostatic Hyperplasia | 1 | 2015 | 210 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 997 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 51 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 1764 | 0.030 |
Why?
|
| Spermine | 1 | 2013 | 25 | 0.030 |
Why?
|
| Sulfites | 1 | 2013 | 44 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2009 | 639 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 2809 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 1516 | 0.030 |
Why?
|
| Lung | 2 | 2020 | 3151 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 4938 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 484 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 4757 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 548 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 1869 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 754 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 931 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 505 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2017 | 2084 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 2218 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 86204 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 526 | 0.020 |
Why?
|
| Research Design | 1 | 2018 | 1544 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 342 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 4988 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Food Contamination | 1 | 2010 | 22 | 0.020 |
Why?
|
| Fishes | 1 | 2010 | 44 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 6311 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 651 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 2170 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 644 | 0.020 |
Why?
|
| Retreatment | 1 | 2010 | 452 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1152 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 2738 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 21445 | 0.020 |
Why?
|
| Anoikis | 1 | 2009 | 63 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2009 | 174 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2012 | 709 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2009 | 113 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 129 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 1443 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2008 | 116 | 0.020 |
Why?
|
| Everolimus | 1 | 2010 | 415 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1582 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 107 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 471 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 717 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 31252 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1165 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2009 | 330 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 3101 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 80 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 3033 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 46 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1503 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 1544 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2015 | 2295 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 11538 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 666 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 1353 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 771 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2007 | 557 | 0.020 |
Why?
|
| Child | 2 | 2019 | 29154 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 5377 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6009 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 674 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 10035 | 0.020 |
Why?
|
| Gene Expression | 2 | 2003 | 3570 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2011 | 3005 | 0.010 |
Why?
|
| Cisplatin | 1 | 2011 | 2432 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 1163 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1832 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4557 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2003 | 67 | 0.010 |
Why?
|
| Oxytocin | 1 | 2003 | 62 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2002 | 80 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2002 | 95 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 4758 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2003 | 208 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2330 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2009 | 1230 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2002 | 157 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 223 | 0.010 |
Why?
|
| Dogs | 1 | 2002 | 1155 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 70117 | 0.010 |
Why?
|
| United States | 1 | 2018 | 15433 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 483 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2009 | 2022 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 614 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2002 | 576 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 5112 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 2944 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1245 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2002 | 787 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 29902 | 0.010 |
Why?
|